drugset / Trial / NCT02170987
Assessment of Electrophysiological Effects of Dabigatran Etexilate as Single Dose on the QT Interval in Healthy Female and Male Subjects.
RandomizedCrossoverDouble-blindTreatment
Summary
To investigate if dabigatran has a clinically relevant impact on the cardiac electrophysiology that is manifest as prolongation in QT-interval.
Timeline
- Start
- 2006-03
- Primary completion
- 2006-05
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dabigatran etexilate | Unknown | 150 mg | — |
| Subject | Dabigatran etexilate | Unknown | 600 mg | — |
| Comparator | Moxifloxacin | Small molecule | — | — |
Indications
No indication recorded.